000 01517 a2200433 4500
005 20250514005057.0
264 0 _c20010830
008 200108s 0 0 eng d
022 _a0340-7004
024 7 _a10.1007/s002620100194
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStanley, A J
245 0 0 _aRenal carcinoma cell lines inhibit natural killer activity via the CD94 receptor molecule.
_h[electronic resource]
260 _bCancer immunology, immunotherapy : CII
_cJul 2001
300 _a260-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntibodies, Monoclonal
_ximmunology
650 0 4 _aAntigens, CD
_ximmunology
650 0 4 _aCarcinoma, Renal Cell
_ximmunology
650 0 4 _aCells, Cultured
650 0 4 _aCytotoxicity Tests, Immunologic
650 0 4 _aCytotoxicity, Immunologic
650 0 4 _aHumans
650 0 4 _aInterleukin-15
_xpharmacology
650 0 4 _aK562 Cells
650 0 4 _aKidney Neoplasms
_ximmunology
650 0 4 _aKiller Cells, Natural
_xdrug effects
650 0 4 _aLectins, C-Type
650 0 4 _aMembrane Glycoproteins
_ximmunology
650 0 4 _aNK Cell Lectin-Like Receptor Subfamily D
650 0 4 _aTumor Cells, Cultured
650 0 4 _aTumor Escape
700 1 _aGough, M J
700 1 _aBanks, R E
700 1 _aSelby, P J
700 1 _aPatel, P M
773 0 _tCancer immunology, immunotherapy : CII
_gvol. 50
_gno. 5
_gp. 260-8
856 4 0 _uhttps://doi.org/10.1007/s002620100194
_zAvailable from publisher's website
999 _c11425035
_d11425035